• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

Box Office: ‘Shang-Chi’ Triumphs Again in Second Weekend, ‘Malignant’ Misfires

September 12, 2021 by David Barret Leave a Comment

September 12, 2021

By Rebecca Rubin

LOS ANGELES (Variety.com) – Marvel’s “Shang-Chi and the Legend of the Ten Rings” ruled the domestic box office again, collecting $35.8 million in its second weekend in theaters.

Ticket sales for the superhero movie, led by Simu Liu and Awkwafina, fell 53% from its debut, a decline on par with many Marvel installments in pre-pandemic times. Notably, “Shang-Chi” is holding up better than “Black Widow,” the comic book adaptation starring Scarlett Johansson, which plummeted nearly 70% in its sophomore outing. “Black Widow” opened simultaneously on Disney Plus (for an extra $30), while “Shang-Chi” is playing only in cinemas.

Box office receipts for “Shang-Chi” appear to be encouraging to Disney, with the studio announcing last week that the rest of its 2021 slate — including Marvel’s “Eternals” and Steven Spielberg’s adaptation of “West Side Story” — will all screen exclusively in theaters. The news is especially promising to theater operators, because Disney films are routinely among the highest-grossing of the year and most multiplexes in the U.S. and Canada have been struggling to sell tickets to movies that are also available at home on streaming platforms.

The weekend’s only new nationwide release, the Warner Bros. horror film “Malignant,” was no match for “Shang-Chi,” with the twisted thriller debuting to $5.57 million from 3,485 locations. That’s a tepid result since horror has been a reliable big-screen during the pandemic, and the film’s director James Wan, the co-creator of “The Conjuring” Universe and the “Saw” franchise, has a solid track record when it comes to cinematic scares. But a bonkers twist ending, as well as decent reviews for the genre (75% on Rotten Tomatoes), weren’t enough to entice audiences to watch a movie that, like each of the studio’s 2021 releases, is available on HBO Max at the same time. It landed a “C” grade on CinemaScore, which doesn’t bode well for its future prospects.

Overseas, “Malignant” made $6.3 million from 69 international markets for an international total of $9.5 million and a global tally of $15.1 million.

“This is a weak opening for a genre that’s held up well during the pandemic,” says David. A Gross, who runs the movie consulting firm Franchise Entertainment Research. “With the film available on HBO, this start is below average.”

To put “Malignant’s” muted opening weekend ticket sales into perspective, it generated nearly the same amount as “Free Guy,” Disney’s sci-fi action comedy with Ryan Reynolds, did in its fifth weekend of release. In second place, “Free Guy” pocketed $5.8 million from 3,650 venues, boosting its domestic tally to $101.5 million, an impressive sum for an original property.

Universal’s slasher film “Candyman” nabbed the No. 4 spot with $4.8 million from 3,279 locations. After three weeks of release, the movie had amassed $48 million in the U.S. and Canada and an additional $10.9 million internationally.

Disney’s family adventure “Jungle Cruise” rounded out the top five, pulling in $2.4 million in its seventh frame.

Source Link Box Office: ‘Shang-Chi’ Triumphs Again in Second Weekend, ‘Malignant’ Misfires

David Barret
David Barret

Related posts:

  1. LG B1 OLED price, release date and specs
  2. HPE signs multi-billion dollar NSA computing deal
  3. American Eagle online sales drop on easing COVID-19 curbs, shares slump
  4. Tracking startup focus in the latest Y Combinator cohort

Filed Under: News

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

  • Some Languages Don’t Clearly Express A Sense Of The Future, And It Skews The Way We See Reality
  • Rare White Kiwi Seen Scampering Back To Its Burrow In Broad Daylight In New Zealand
  • What Is Osmotic Power? Japan’s New Renewable Energy Plant Goes Live
  • The “Wow!” Signal Was Likely From An Extraterrestrial Source, And More Powerful Than We Thought
  • The Greatest Prank Ever Pulled In Space Really Fooled NASA’s Mission Control
  • Why Does Seafood Glow In The Dark? This Curious Phenomenon Has A Teeny Tiny Explanation
  • In 1973, A Handful Of People Witnessed A Whopping 74-Minute Total Eclipse
  • Does Putting A Metal Spoon In Champagne Really Keep It Fizzy?
  • Why Scientists Are Going Over A Kilometer Underground In The Search For Alien Life
  • The Deadliest Animal In The US Isn’t What You’d Expect
  • Humpback Whale Flippers Let Them Move “Like Underwater Fighter Pilots” To Make Unique Bubble Nets
  • The Only Place On Earth Where You (Yes, You) Can Search For Diamonds – And Keep What You Find
  • Bizarre Gravitational Collisions Reveal Hints Of First Black Hole Throuple
  • Newly Discovered Dinosaur’s “Sail-Like” Structure Along Its Back May Have Attracted Mates
  • What Are Lagrange Points, And Why Are They Important?
  • Fish Left The Ocean 10 Million Years Earlier Than Thought, JWST Spots Tiny New Moon Just Outside Uranus’s Rings, And Much More This Week
  • IFLScience We Have Questions: Do Humans Have Pheromones?
  • The Least Visited Place On Earth Is Disappearing Quickly – And May Be Reborn Online
  • Climate Models Have Predicted Sea Level Rise Almost Perfectly For 30 Years
  • Atlantic Great White Sharks Are Creeping Up The East Coast Of The US And Canada
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2025 · Medical Market Report. All Rights Reserved.

Go to mobile version